On the stock market since 2013, it operates in the world of health and science. It has 12 employees. Now — the numbers.
This is an established company with proven profits.
The biggest line carries real weight, but it doesn’t decide everything on its own.
Average growth of 17% a year over the last 4 years. Red columns mark years that ended in a loss.
If every debt were paid off today, $616K would still be left in the vault — a solid cushion for hard times.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
An investor who bought at the very peak is down 67% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
The net profit margin is 17% — still a thick cushion, though costs have been eating into it lately.
Over the last 3 years, sales grew about 29% a year on average.
There is $636K in the vault; even if every debt were paid off, $616K would remain.
The stock sits at $0.30. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
Over the last 12 months, executives reported 5 sells against just 1 buy. Not an alarm bell by itself, but a number worth watching.
On our five-subject report card, USAQ sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: USAQ is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.